US Broker Ratings

Legend Biotech Corporation (LEGN) Stock Analysis: Potential 198.94% Upside in the Booming Cell Therapy Market

Legend Biotech Corporation (NASDAQ: LEGN) presents a compelling opportunity for investors seeking exposure to the innovative field of biotechnology, particularly in the burgeoning cell therapy sector...

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring an 81% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a key player in the healthcare sector, is capturing investor attention with a compelling upside potential of 81.02%. Specializing in medical..

Repligen Corporation (RGEN) Investor Outlook: Potential 58.62% Upside Sparks Interest

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector, specializes in developing and commercializing bioprocessing technologies that are indispensable for the life sciences industry...

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 7.37% Upside Potential Amidst Strong Buy Ratings

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling case for investors seeking growth..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 50.66% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors eyeing..

Oscar Health, Inc. (OSCR) Stock Analysis: Unpacking the 29% Potential Upside

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, has been making waves in the healthcare plans industry with its innovative approach to health insurance. With..

BrightSpring Health Services, Inc. (BTSG) Investor Outlook: A 22% Upside Potential Amid Robust Revenue Growth

For investors seeking opportunities in the healthcare sector, BrightSpring Health Services, Inc. (BTSG) presents a compelling case. As a leading provider of home and community-based healthcare..

Sarepta Therapeutics, Inc. (SRPT): Stock Analysis Reveals Challenges Amidst Biotech Innovations

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a prominent player within the biotechnology sector, focusing on the development of genetic therapeutic modalities targeting rare diseases. The..

West Pharmaceutical Services (WST) Stock Analysis: A Steady Healthcare Innovator with 24% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector, specializing in medical instruments and supplies, presents an intriguing opportunity for investors seeking..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with a 19.55% Potential Upside

Investors eyeing the biotechnology sector may find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) a compelling opportunity, given its promising pipeline and a notable 19.55% potential upside. This..

Grifols, S.A. (GRFS) Stock Analysis: Potential 34.71% Upside Catches Investor Attention

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is capturing the attention of investors with its intriguing market dynamics and forward-looking potential. As..

Exelixis, Inc. (EXEL) Investor Outlook: Navigating a 6.73% Potential Upside in the Biotechnology Sector

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to capture investor interest with its robust oncology portfolio and strategic collaborations. Headquartered in..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Unveiling a 13% Potential Upside for Investors

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a prominent player in the medical technology sector, with a focus on orthopedic reconstructive products and cutting-edge surgical..

ResMed Inc. (RMD) Stock Analysis: Exploring a 32% Upside Potential for the Healthcare Innovator

For investors seeking to enhance their portfolios with promising healthcare stocks, ResMed Inc. (NYSE: RMD) presents a compelling opportunity. ResMed, a leader in developing innovative medical..

Koninklijke Philips N.V. (PHG) Stock Report: Exploring a 24.46% Upside Potential for Investors

Investors seeking opportunities in the healthcare sector might find Koninklijke Philips N.V. (NYSE: PHG) an intriguing option, especially given its potential upside of 24.46%. With its..

Molina Healthcare Inc (MOH) Investor Outlook: Navigating the Healthcare Plans Sector with a Potential 8% Upside

Molina Healthcare Inc (NYSE: MOH), a pivotal player in the Healthcare Plans industry, presents an intriguing opportunity for investors focused on managed healthcare services. Headquartered in..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unveiling a 166% Potential Upside for Investors

Soleno Therapeutics, Inc. (NASDAQ: SLNO) has emerged as a compelling prospect within the biotechnology sector, capturing investor attention with a staggering potential upside of 166.28%. With..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential with a 4.21% Upside

DaVita Inc. (NYSE: DVA), a major player in the healthcare sector specializing in kidney dialysis services, presents an intriguing prospect for investors with its recent financial..

Cytokinetics, Inc. (CYTK) Stock Analysis: Unveiling a Promising 39% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands at the forefront of the biotechnology sector, carving out its niche by focusing on the development of muscle activators and inhibitors..

Bruker Corporation (BRKR) Stock Analysis: Navigating a 30% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector’s medical devices industry, presents an intriguing opportunity for investors seeking exposure to scientific and analytical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds